Search details
1.
Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma.
Br J Surg
; 111(2)2024 Jan 31.
Article
in English
| MEDLINE | ID: mdl-38377361
2.
Outcomes of patients with esophageal squamous cell carcinoma who achieved a pathological complete response in the primary lesion by neoadjuvant treatment: a Japanese nationwide cohort study.
Esophagus
; 21(1): 2-10, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37999900
3.
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Ann Surg
; 278(2): e234-e239, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-36538635
4.
Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score-matched Analysis From 85 Authorized Institutes for Esophageal Cancer in Japan.
Ann Surg
; 278(1): e35-e42, 2023 Jul 01.
Article
in English
| MEDLINE | ID: mdl-35837977
5.
Stratification of Stage II Colon Cancer Using Recurrence Prediction Value: A Multi-institutional International Retrospective Study.
Ann Surg
; 2023 Oct 12.
Article
in English
| MEDLINE | ID: mdl-37823278
6.
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in Japan.
Ann Surg Oncol
; 30(4): 2176-2185, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36528742
7.
Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide Study.
Ann Surg Oncol
; 30(9): 5885-5894, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37264286
8.
Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
; 30(6): 3747-3756, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36788188
9.
Five-Year Outcomes of the Bioresorbable Peripheral Remedy Stent in the Treatment of Iliac Artery Disease.
J Vasc Interv Radiol
; 34(6): 1024-1035.e2, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36806564
10.
The impact of thoracic duct resection on the long-term body composition of patients who underwent esophagectomy for esophageal cancer and survived without recurrence.
Dis Esophagus
; 36(9)2023 Sep 01.
Article
in English
| MEDLINE | ID: mdl-37465862
11.
Old age and intense chemotherapy exacerbate negative prognostic impact of postoperative complication on survival in patients with esophageal cancer who received neoadjuvant therapy: a nationwide study from 85 Japanese esophageal centers.
Esophagus
; 20(3): 445-454, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36662353
12.
A nationwide validation of the prognostic impact of pathological response and the distribution of recurrence patterns in responders after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Esophagus
; 20(2): 205-214, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36319809
13.
Prognostic impact of endoscopic response evaluation after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a nationwide validation study.
Esophagus
; 20(3): 455-464, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36964333
14.
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan.
Esophagus
; 20(3): 465-473, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37029845
15.
Exposure to a Postoperative Hypercoagulable State Predicts Poor Prognosis After Transthoracic Esophagectomy in Patients with Esophageal Cancer.
Ann Surg Oncol
; 2022 Mar 28.
Article
in English
| MEDLINE | ID: mdl-35347519
16.
Early prediction model of organ/space surgical site infection after elective gastrointestinal or hepatopancreatobiliary cancer surgery.
J Infect Chemother
; 26(9): 916-922, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32360091
17.
ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
; 30(4): 2186-2187, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36538253
18.
ASO Visual Abstract: Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment-A Nationwide, Retrospective Study in Japan.
Ann Surg Oncol
; 30(4): 2188-2189, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36602666
19.
ASO Visual Abstract: Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
; 30(6): 3759, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37016011
20.
ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study.
Ann Surg Oncol
; 30(9): 5895-5896, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37266806